Broadcasting News

Park Mi-sun and Lee Bong-won’s Son Changes His Name and Pursues Acting Career: “I Want to Do This Without My Parents’ Help”

Cho Hye-ryeon: "We Met at a Theater Audition" "I Used to Dream of Being a Comedian, but Now I Suddenly Want to Be an Actor"

[Edaily Starin Gim Ga Yeong Reporter] It has been reported that Lee Sang-yeop, the son of comedian couple Park Mi-sun and Lee Bong-won, has changed his surname and is now active under the name Choi Sang-yeop.
On the 30th of last month, Park Mi-sun appeared in the video “New Woman” on the YouTube channel “Rolling Thunder” and opened up about her son, Choi Chang-yeop.
Jo Hye-ryeon told Park Mi-sun, “I heard your son changed his last name and is working as an actor.” She went on to say that she met Park Mi-sun’s son at a theater audition two years ago, adding, “I found out later that he was your son. I was surprised that he’d changed his last name. He’s so cute, handsome, and a great actor.”
She continued, “Lee Bong-won came to see the performance but didn’t recognize my son. He asked, ‘Where’s Sang-yeop?’ That’s how well he acts.”
Park Mi-sun revealed, “You can’t control your children. I hoped he wouldn’t pursue acting, but that didn’t work out.” She continued, “When my son was young, his dream was to be a comedian, so we taught him how to be funny. But one day, he suddenly said he wouldn’t be a comedian and would become an actor instead. He’s doing it all on his own—even changing his name—without any help from us.”
Choi Sang-yeop is signed to Cube Entertainment, the same agency as his mother, Park Mi-sun. After making his debut in March 2023 with the play “The Republic of Korea Theater Festival: The Story of Baeso-goji,” he has continued his acting career through productions such as “Body Change” and “The Trial of Hamlet.”

Economy

Corporation

IT·Science

Economy

A Semiconductor Fabless Company Founded by SK Hynix’s Youngest-Ever Executive [VC Cradle]

The biggest bottleneck for AI servers is memory. As the KV cache—where large language models (LLMs) store past computations—accumulates, the required memory capacity increases exponentially. This prob…
2026-07-04 09:00:07

Corporation

Genosco, Tax Risk?… “Lecraza Is ‘Royalty Income’; Its Value Remains Unchanged”

Concerns about “tax risks” have been raised in some quarters of the financial investment, pharmaceutical, and biotech markets regarding Genosco, a subsidiary of OSCOTEC Inc.(039200)specializing in new…
2026-07-04 08:31:02

IT·Science

Celltrion Pharm Inc. Builds a Plant, AriBio Secures Investment… K-Bio in ‘Expansion Mode’ [Weekly Bio Roundup]

As July began (June 29–July 3), the pharmaceutical and biotech industries turned their attention to Celltrion Pharm Inc.’s large-scale investment in production facilities and AriBio’s successful fundr…
2026-07-04 09:01:02